Pediatric acute kidney support therapy (paKST) programs aim to reliably provide safe, effective, and timely extracorporeal supportive care for acutely and critically ill pediatric patients with acute kidney injury (AKI), fluid and electrolyte derangements, and/or toxin accumulation with a goal of improving both hospital-based and lifelong outcomes. Little is known about optimal ways to configure paKST teams and programs, pediatric-specific aspects of delivering high-quality paKST, strategies for transitioning from acute continuous modes of paKST to facilitate rehabilitation, or providing effective short- and long-term follow-up. As part of the 26th Acute Disease Quality Initiative Conference, the first to focus on a pediatric population, we summarize here the current state of knowledge in paKST programs and technology, identify key knowledge gaps in the field, and propose a framework for current best practices and future research in paKST.

儿科急性肾脏支持治疗 (paKST) 计划旨在为患有急性肾损伤 (AKI)、体液和电解质紊乱和/或毒素蓄积的急性和危重症儿科患者可靠地提供安全、有效和及时的体外支持护理改善医院和终生结果。人们对配置 pKST 团队和项目的最佳方法、提供高质量 pKST 的儿科特定方面、从 pKST 急性连续模式过渡到促进康复的策略或提供有效的短期和长期随访的策略知之甚少。作为第 26 届急性疾病质量倡议会议（首次关注儿科人群）的一部分，我们在此总结了 paKST 计划和技术的当前知识状况，确定了该领域的关键知识差距，并提出了当前最佳实践的框架以及paKST 的未来研究。